Genomcore raises 919,610 euros of Next Generation funds for personalized medicine

Genomcore has raised €919,610 in Next Generation funds for the development of a project to implement personalized medicine solutions for cancer patients with metastases.

Share this article

Leer en Español

Genomcore has raised €919,610 in Next Generation funds for the development of a project to implement personalized medicine solutions for cancer patients with metastases.

Related articles

Genomcore team at the European Human Genetics Conference 2026

Genomcore at ESHG 2026: from the lab to the clinical decision

María Díez, QARA Lead at Genomcore, presenting the Made of Genes and Genomcore solution at the EU AI Sandbox closing ceremony

Genomcore passes the first EU AI Sandbox through its spin-off, Made of Genes

David G. Pisano, Clinical Bioinformatics Director at Genomcore, participating in the roundtable on management and analysis models in the NHS during the 1st Clinical Bioinformatics Conference organized by SEBiBC at ISCIII, Madrid

Genomcore at the 1st SEBiBC Clinical Bioinformatics Conference: clinical bioinformatics that reaches the patient